CYP2C19 and chronic kidney disease: The ABCD-GENE risk score confirmed a proposition of clinical and genotype components to identify patients at HRPR on clopidogrel in different populations with age, BMI, CKD, diabetes, and CYP2C19 LOF alleles (Angiolillo et al., 2020).